title: Mumps in Poland in 2011.
abstract: BACKGROUND
  In 2011, similarly to previous years a decline was observed in the number of recorded cases of mumps. This favourable epidemiological situation is a result of mumps vaccination program, which from 2003 became mandatory given as two dose schemes with MMR vaccine (mumps, measles, and rubella).
  
  
  OBJECTIVE
  The aim of this work was to assess mumps epidemiological situation in Poland in 2011, in comparison to previous years.
  
  
  METHODS
  The assessment of mumps epidemiological situation in Poland in 2011 was conducted by using the results of analyzed data for infectious diseases published in a yearly bulletin "Infectious diseases and poisoning in Poland in 2011" and in yearly bulletin "Preventative immunisation in Poland in 2011" Czarkowski MP and in, Warsaw, NIZP- PZH and GIS. Also used "Case definitions for infectious disease developed for epidemiological surveillance in the years 2009-2011 " (Department of Epidemiology, NIZP-PZH), as well as Preventative vaccination program 2011.
  
  
  RESULTS
  In 2011 there were 2585 reported cases of mumps. Incidence of mumps was lower 6.7/100 in comparison with 2010 (7.2/100), as well as almost twice lower than a median for the years 2005-2009. The highest incidents rate of mumps 52.0/100,000 was recorded among children at the age 5-9 years of age. Incidence in women was lower (5.6) than in men (7.9). In 2011, 24 people were hospitalized due to mumps.
  
  
  CONCLUSIONS
  Systematic implementation of vaccination program against mumps as according to Inoculation Calendar has resulted in a significant decline in the number of reported cases.
authors.affiliation: Department of Epidemiology, National Institute of Public Health- National Institute of Hygiene, Warsaw, Poland. mgluchowska@pzh.gov.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Lipke
authors.forename: Iwona
authors.initials: I
authors.lastname: Paradowska-Stankiewicz
mesh_terms: D000293:Adolescent; D017677:Age Distribution; D002648:Child; D002669:Child Welfare / Q000706:statistics & numerical data*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D032541:Mass Vaccination / Q000706:statistics & numerical data; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage*; D009107:Mumps / Q000453:epidemiology* / Q000517:prevention & control*; D011044:Poland / Q000453:epidemiology; D011322:Primary Prevention / Q000458:organization & administration; D012042:Registries / Q000706:statistics & numerical data*; D012307:Risk Factors; D019213:Rubulavirus / Q000302:isolation & purification; D012424:Rural Population / Q000706:statistics & numerical data; D014505:Urban Population / Q000706:statistics & numerical data
chemical_list: D022542:Measles-Mumps-Rubella Vaccine